Medical device companies are increasingly looking at digital health and diagnostics solutions to bolster their portfolios.
This week, Thermo Fisher Scientific announced plans to acquire molecular diagnostic company Mesa Biotech, Inc. for $450m in...
Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
